跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 30 条关于
“IgGenix”
全部
30
临床试验
8
药物
5
机构
7
资讯
10
去年
IgGenix Completes Enrollment for First-in-Human Trial of Novel Peanut Allergy Antibody Therapy
去年
IgGenix Doses First Patient in Phase 1 Trial of IGNX001 for Peanut Allergy
去年
U.S. Monoclonal Antibodies Market Projected to Reach $284.9 Billion by 2034, Growing at 13.1% CAGR
去年
Ingenix Secures €9M Seed Funding to Revolutionize Clinical Trials with AI Simulation
10个月前
EirGenix Secures $152M Licensing Deal with Sandoz for HER2-Positive Breast Cancer Biosimilar
8个月前
Transcenta Therapeutics Partners with EirGenix to License Continuous Biomanufacturing Platform for Affordable Biologics
10个月前
Tissue Regenix Faces Urgent Funding Crisis as Regenerative Medicine Company Seeks £5M to Avoid Insolvency
3个月前
Ingenia Therapeutics Receives KRX Approval for IPO as TIE2-Targeted Therapies Advance to Phase 3
9天前
Cellipont and Xiogenix White Paper Shows Automated Fill-Finish Maintains Cell Viability Across 17-Fold Scale-Up
3个月前
EirGenix Advances Dual-Track Biosimilar and CDMO Strategy, Targeting HER2-Positive Breast Cancer and Global Supply Chain Opportunities